ENHANCING ONCOLOGY INVESTIGATION WITH INTEGRATED KRAS ASSAY EXPERT SERVICES AND RAS ASSAYS

while in the swiftly evolving subject of oncology exploration, accurate and efficient mutation screening is vital for building focused therapies. The KRAS providers Platform performs a pivotal part In this particular landscape by providing complete solutions for KRAS mutation profiling and Assessment. KRAS mutations, located in close to 95% of RAS-